PTPRC and cervical cancer: The gating strategy for macrophages isolated from viable CD45+ mononuclear cells of human cervical cancer was shown in Fig. 2A. TAM was defined by CD45+CD14+CD11b+CD68+ and accounted for 3%-6% of all viable CD45+ leucocytes in cervical cancer.